Raw Material Identity Testing Inspection Checklist [FREE PDF]

Pharmaceutical manufacturers are required under FDA 21 CFR 211.84 to conduct identity testing on each lot of component received before use in drug product manufacturing to prevent adulteration and substitution. ICH Q7 Section 7.1 and WHO GMP Guidelines further mandate that APIs and raw materials be tested against established specifications using validated analytical methods. Proper identity testing, documentation, and material disposition controls are foundational to cGMP compliance and regulato

Industry: Pharmaceutical Manufacturing
Frequency: Per Event
Estimated Time: 45-60 minutes
Role: Quality Manager
Total Items: 41
Compliance: FDA 21 CFR 211.84 - Testing and approval or rejection of components, FDA 21 CFR 211.87 - Retesting of approved components, ICH Q7 Section 7.1 - General Controls for Materials Management, USP <1> Injections and Implanted Drug Products (General Notices), WHO GMP Guidelines - Section 14: Quality Control

Material Receipt & Shipment Verification

Confirm incoming raw material shipment integrity, labeling accuracy, and chain-of-custody documentation upon receipt.

Does the supplier Certificate of Analysis (CoA) accompany the shipment?
Does the material label information match the purchase order and CoA (name, grade, lot number)?
Are all containers in the shipment intact, properly sealed, and free of visible damage?
Has the material been placed in quarantine pending identity testing and release?
Is the quarantine area physically segregated or electronically controlled to prevent unauthorized use?

Visual & Physical Inspection

Conduct macroscopic evaluation of material appearance, color, odor, and physical form against established specifications.

Does the material appearance (color, form, texture) conform to the approved specification?
Is the material free of foreign particulates, discoloration, or visible contamination?
Is the odor of the material consistent with the reference standard or specification description?
Has a photograph of the material's physical appearance been captured and stored in the batch record?
Are any anomalies in physical inspection documented in the receiving log with date, time, and observer?

Sampling Procedures & Chain of Custody

Verify that sampling is performed per approved SOPs using validated tools and that sample integrity is maintained throughout.

Was sampling performed by a trained and qualified analyst per an approved sampling SOP?
Was the correct statistical sampling plan applied (e.g., n = 1 + √N containers)?
Were sampling tools (spatulas, scoops, sample bags) dedicated or properly cleaned and documented?
Are sample labels affixed with material name, lot number, sample date, and analyst ID?
Has a chain-of-custody form been completed and signed for all samples sent to the QC laboratory?

Identity Testing Methods

Confirm that appropriate validated analytical methods are used to confirm raw material identity per compendial or in-house specifications.

Has IR spectroscopy (or equivalent identity test) been performed on each container sampled?
Does the IR spectrum (or test result) match the reference standard or approved comparator?
Was the analytical method used for identity testing validated per an approved validation protocol?
Select the primary identity testing method used for this material?
Has the instrument used for identity testing been calibrated and verified within the required period?
Were reagent or reference standard lot numbers recorded in the laboratory notebook or LIMS?

Specification Compliance Testing

Evaluate additional quality attributes (assay, moisture, purity, heavy metals) against the approved material specification.

Has assay testing been performed and does the result meet the specification limit?
Does the moisture content (LOD or KF) meet the specification limit?
Are related substances or impurity profiles within specification limits?
Has heavy metal or elemental impurity testing been completed where required by specification?
Do all specification test results conform to the approved Certificate of Analysis from the supplier?

Material Disposition & Labeling

Confirm proper disposition decisions are made, documented, and communicated following completion of identity and quality testing.

Has the Quality Control unit formally approved or rejected the material based on test results?
Has the material status label (Approved / Rejected / Quarantine) been updated in the warehouse system?
Are rejected materials physically segregated and locked to prevent inadvertent use?
Has the material approval been entered into the ERP or inventory management system with lot traceability?
Has the supplier been notified of any out-of-specification results or quality concerns?

Storage Conditions Verification

Confirm that approved raw materials are stored under conditions specified on the label and in the material monograph.

Is the storage area temperature within the specified range for this material?
Is the relative humidity in the storage area within the specification for this material?
Are light-sensitive materials stored in appropriate light-protective containers or areas?
Is the retest or expiry date visible on each container and within the acceptable period?
Are temperature and humidity data loggers in the storage area calibrated and data downloaded within the required frequency?

Documentation & Data Integrity

Review completeness, accuracy, and regulatory compliance of all raw material testing and receipt documentation.

Are all raw material test results entered contemporaneously in the official laboratory notebook or LIMS?
Are corrections to written records made with a single line through the error, dated, and initialed?
Are electronic raw data files backed up and protected against deletion or unauthorized modification?
Has the completed receiving and testing package been reviewed and signed by a second qualified reviewer?
Will all raw material identity records be retained for the required regulatory period?

Related Pharmaceutical Checklists

Related Quality Control Checklists

Why Use This Raw Material Identity Testing Inspection Checklist [FREE PDF]?

This raw material identity testing inspection checklist [free pdf] helps pharmaceutical manufacturing teams maintain compliance and operational excellence. Designed for quality manager professionals, this checklist covers 41 critical inspection points across 8 sections. Recommended frequency: per event.

Ensures compliance with FDA 21 CFR 211.84 - Testing and approval or rejection of components, FDA 21 CFR 211.87 - Retesting of approved components, ICH Q7 Section 7.1 - General Controls for Materials Management, USP <1> Injections and Implanted Drug Products (General Notices), WHO GMP Guidelines - Section 14: Quality Control. Regulatory-aligned for audit readiness and inspection documentation.

Frequently Asked Questions

What does the Raw Material Identity Testing Inspection Checklist [FREE PDF] cover?

This checklist covers 41 inspection items across 8 sections: Material Receipt & Shipment Verification, Visual & Physical Inspection, Sampling Procedures & Chain of Custody, Identity Testing Methods, Specification Compliance Testing, Material Disposition & Labeling, Storage Conditions Verification, Documentation & Data Integrity. It is designed for pharmaceutical manufacturing operations and compliance.

How often should this checklist be completed?

This checklist should be completed per event. Each completion takes approximately 45-60 minutes.

Who should use this Raw Material Identity Testing Inspection Checklist [FREE PDF]?

This checklist is designed for Quality Manager professionals in the pharmaceutical manufacturing industry. It can be used for self-assessments, team audits, and regulatory compliance documentation.

Can I download this checklist as a PDF?

Yes, this checklist is available as a free PDF download. You can also use it digitally in the POPProbe mobile app for real-time data capture, photo documentation, and automatic reporting.